Filings - Clinical Trials Arena https://www.clinicaltrialsarena.com/filings/ Hard data and deep insights on clinical trials strategy & operations Fri, 22 Dec 2023 12:26:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Filings - Clinical Trials Arena https://www.clinicaltrialsarena.com/filings/ 32 32 Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio https://www.clinicaltrialsarena.com/news/signal-lilly-searches-for-new-obesity-drugs-in-partnership-with-fauna-bio/ Fri, 22 Dec 2023 12:13:49 +0000 https://www.clinicaltrialsarena.com/uncategorized/signal-lilly-searches-for-new-obesity-drugs-in-partnership-with-fauna-bio/ The deal is worth up to $494m plus royalties and allows Lilly to utilise Fauna’s Convergence artificial intelligence platform.

The post Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio appeared first on Clinical Trials Arena.

]]> The post Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio appeared first on Clinical Trials Arena.

]]> Signal: Illumina to divest Grail, ending years-long legal battle https://www.clinicaltrialsarena.com/news/illumina-to-divest-grail-ending-years-long-legal-battle/ Mon, 18 Dec 2023 14:52:21 +0000 https://www.clinicaltrialsarena.com/?p=194189 Both the European Commission and the US' Federal Trade Commission have taken issue with Illumina’s reacquisition of Grail.

The post Signal: Illumina to divest Grail, ending years-long legal battle appeared first on Clinical Trials Arena.

]]> The post Signal: Illumina to divest Grail, ending years-long legal battle appeared first on Clinical Trials Arena.

]]> Signal: FDA renews Syapse collaboration to use real-world data in oncology https://www.clinicaltrialsarena.com/news/signal-fda-renews-syapse-collaboration-to-use-real-world-data-in-oncology/ Wed, 06 Dec 2023 16:56:34 +0000 https://www.clinicaltrialsarena.com/news/signal-fda-renews-syapse-collaboration-to-use-real-world-data-in-oncology/ The collaboration focuses on the evaluation of real-world data study designs and methods for informing regulatory objectives.

The post Signal: FDA renews Syapse collaboration to use real-world data in oncology appeared first on Clinical Trials Arena.

]]> The post Signal: FDA renews Syapse collaboration to use real-world data in oncology appeared first on Clinical Trials Arena.

]]> Signal: Wegovy highlights UK’s complex relationship with private sector https://www.clinicaltrialsarena.com/news/wegovy-highlights-uks-complex-relationship-with-private-sector/ Mon, 20 Nov 2023 16:09:28 +0000 https://www.clinicaltrialsarena.com/uncategorized/wegovy-highlights-uks-complex-relationship-with-private-sector/ Wegovy has made headlines recently in the UK, highlighting both its seismic impact and changes in health habits.

The post Signal: Wegovy highlights UK’s complex relationship with private sector appeared first on Clinical Trials Arena.

]]> The post Signal: Wegovy highlights UK’s complex relationship with private sector appeared first on Clinical Trials Arena.

]]> Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients https://www.clinicaltrialsarena.com/news/wegovy-cuts-cardiovascular-risk-by-20-for-heart-disease-patients/ Mon, 13 Nov 2023 14:36:15 +0000 https://www.clinicaltrialsarena.com/?p=191860 Novo Nordisk announced this week that its weight loss drug Wegovy reduces the risk of major cardiovascular events by 20%.

The post Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients appeared first on Clinical Trials Arena.

]]> The post Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients appeared first on Clinical Trials Arena.

]]> How did the pharmaceutical industry treat regenerative medicine in Q3 2023 filings? https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-regenerative-medicine-in-q3-2023-filings/ https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-regenerative-medicine-in-q3-2023-filings/#respond Mon, 06 Nov 2023 00:04:42 +0000

The post How did the pharmaceutical industry treat regenerative medicine in Q3 2023 filings? appeared first on Clinical Trials Arena.

]]>

The post How did the pharmaceutical industry treat regenerative medicine in Q3 2023 filings? appeared first on Clinical Trials Arena.

]]> https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-regenerative-medicine-in-q3-2023-filings/feed/ 0 How did the pharmaceutical industry treat artificial intelligence in Q3 2023 filings? https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-artificial-intelligence-in-q3-2023-filings/ https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-artificial-intelligence-in-q3-2023-filings/#respond Mon, 06 Nov 2023 00:29:24 +0000

The post How did the pharmaceutical industry treat artificial intelligence in Q3 2023 filings? appeared first on Clinical Trials Arena.

]]>

The post How did the pharmaceutical industry treat artificial intelligence in Q3 2023 filings? appeared first on Clinical Trials Arena.

]]> https://www.clinicaltrialsarena.com/data-insights/how-did-the-pharmaceutical-industry-treat-artificial-intelligence-in-q3-2023-filings/feed/ 0 Signal: Intuitive Surgical’s stock plummets despite Q3 sales growth https://www.clinicaltrialsarena.com/news/intuitive-surgical-q3-results-plummet-shares-despite-sales-growth/ Fri, 20 Oct 2023 16:29:31 +0000 https://www.clinicaltrialsarena.com/uncategorized/intuitive-surgical-q3-results-plummet-shares-despite-sales-growth/

The post Signal: Intuitive Surgical’s stock plummets despite Q3 sales growth appeared first on Clinical Trials Arena.

]]>

The post Signal: Intuitive Surgical’s stock plummets despite Q3 sales growth appeared first on Clinical Trials Arena.

]]> Signal: Project NextGen continues with $500m funding for vaccine research https://www.clinicaltrialsarena.com/news/signal-project-nextgen-continues-with-500m-funding-for-vaccine-research/ Mon, 16 Oct 2023 13:40:34 +0000 https://www.clinicaltrialsarena.com/uncategorized/signal-project-nextgen-continues-with-500m-funding-for-vaccine-research/ The US government's Covid-19 research programme has announced the vaccine candidates for its latest round of funding.

The post Signal: Project NextGen continues with $500m funding for vaccine research appeared first on Clinical Trials Arena.

]]> The post Signal: Project NextGen continues with $500m funding for vaccine research appeared first on Clinical Trials Arena.

]]> Signal: Palantir set to win UK National Health Service overhaul contract https://www.clinicaltrialsarena.com/news/signal-palantir-set-to-win-uk-national-health-service-overhaul-contract/ Wed, 04 Oct 2023 13:40:00 +0000 https://www.clinicaltrialsarena.com/?p=188927 The data and defense company may win a contract to overhaul the UK health service's data collection and management.

The post Signal: Palantir set to win UK National Health Service overhaul contract appeared first on Clinical Trials Arena.

]]> The post Signal: Palantir set to win UK National Health Service overhaul contract appeared first on Clinical Trials Arena.

]]>